Begin main content

Interferon-free Regimens for Chronic Hepatitis C Genotype 1

Published on: June 26, 2014
Project Number: RB0700-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical evidence regarding the use of boceprevir, simeprevir, sofosbuvir, and telaprevir interferon-free regimens for chronic Hepatitis C genotype 1?
  2. What is the cost-effectiveness of boceprevir, simeprevir, sofosbuvir, and telaprevir interferon-free regimens for chronic Hepatitis C genotype 1?

Key Message

Six conference abstracts presenting data from randomized controlled trials and five conference abstracts presenting data from non-randomized studies regarding the use of boceprevir, simeprevir, sofosbuvir, and telaprevir interferon-free regimens for chronic Hepatitis C genotype 1 were identified.

Tags

hepatitis c, hepatitis, IFN free, Incivek, Victrelis, Sovaldi, Galexos, genotype 1, genotype one